Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pediatric Gastroenterology · Familial Hypobetalipoproteinemia Type 1

Recognizing Symptoms and Vitamin Deficiencies

At a Glance

In severe FHBL1 caused by changes in both gene copies, poor fat absorption can cause oily stools, poor growth, and low vitamins A, D, E, and K. Specialist monitoring and early treatment may protect vision, nerves, and bones; sudden vision or neurologic changes require emergency care.

In Familial Hypobetalipoproteinemia Type 1 (FHBL1), the primary challenge in severe cases is the body’s inability to move essential fats and vitamins from the intestines to the rest of the body [1]. While many people with one mutated gene (heterozygotes) remain asymptomatic and have adequate fat absorption, those with biallelic variants (homozygous or compound heterozygous patients) face significant health challenges that require lifelong management [2][1].

Signs of Fat Malabsorption

For those with severe, biallelic forms of FHBL1, the most immediate symptoms are often digestive. Because the body cannot adequately transport dietary fat out of the intestinal cells, the fat stays behind [3]. This leads to:

  • Steatorrhea: Stools that are oily, pale, foul-smelling, and often float [2][4].
  • Chronic Diarrhea: Frequent, loose stools that occur after eating fat [3].
  • Failure to Thrive: In infants and young children, this is a critical sign where the child does not gain weight or grow at the expected rate due to a lack of absorbed calories and nutrients [1][3].

The Role of Fat-Soluble Vitamins

Vitamins A, D, E, and K are “fat-soluble,” meaning they must be absorbed along with fats [5]. In severe FHBL1, these vitamins can become dangerously low, leading to progressive health issues:

  • Vitamin E and A Deficiency: These are particularly critical. Long-term chronic deficiency can lead to retinal degeneration (a progressive eye disease causing night blindness and visual loss) and neuropathy (nerve damage causing loss of balance, coordination issues, and altered reflexes) [1][2][6]. Early treatment may slow this progression.
  • Vitamin D Deficiency: Low levels are common and can lead to weakened bones over time [5].
  • Vitamin K1: Some research has noted lower Vitamin K1 levels even in heterozygous patients [7]. However, this is not a standard diagnostic test, and a low serum value does not by itself establish a bleeding risk without appropriate coagulation evaluation.

Hematologic Changes: Acanthocytosis

In some patients with severe biallelic disease or look-alike conditions like abetalipoproteinemia, the lack of proper fats in the blood changes the structure of red blood cells. This condition is called acanthocytosis [4]. Under a microscope, these cells appear “spiny” or misshapen [8]. While this doesn’t always cause symptoms, it is a marker seen in severe forms where the body’s lipid transport system is highly compromised [8][4]. It is not a routine screening finding for typical heterozygotes.

Urgent Warning Signs vs. Chronic Symptoms

While FHBL1 causes chronic, progressive complications from malabsorption, certain sudden symptoms require urgent medical assessment because they could indicate a different, acute emergency:

  1. Sudden Vision Changes: Any sudden, new difficulty seeing at night or a “tunneling” of the visual field should be reported immediately. Sudden vision loss requires emergency assessment because it could indicate a retinal detachment, stroke, or other acute problem, rather than simply progressive vitamin deficiency [1][2].
  2. Sudden Neurological Changes: Sudden weakness, sudden inability to walk, or acute facial drooping require immediate emergency assessment to rule out stroke or other acute neurological events.
  3. Failure to Thrive in Infants: If a baby with known or suspected biallelic FHBL1 stops gaining weight or begins losing weight, they need prompt evaluation by a pediatric GI or metabolic specialist [1][9].

For most biallelic patients, early and consistent monitoring by a specialist can manage vitamin levels to protect the eyes and nerves from the long-term effects of malabsorption [2][5].

Common questions in this guide

What symptoms can severe FHBL1 cause?
Severe FHBL1 can cause oily, pale, foul-smelling stools, chronic diarrhea after eating fat, and poor weight gain or growth in infants and children. Many people with one altered gene have few or no symptoms, while disease involving both gene copies is more likely to cause significant malabsorption.
Why can FHBL1 cause low vitamins A, D, E, and K?
These vitamins must be absorbed together with dietary fat. When severe FHBL1 prevents the intestine from transporting fat properly, the body may not absorb enough of these vitamins.
What problems can vitamin deficiency cause in FHBL1?
Long-term vitamin A and E deficiency can contribute to progressive retinal disease, night blindness, visual loss, and nerve damage affecting balance and coordination. Vitamin D deficiency can weaken bones, and early treatment may help slow some complications.
When are vision or neurologic changes an emergency?
Sudden vision loss, a new tunnel-like visual field, sudden weakness, inability to walk, or facial drooping needs immediate emergency assessment. These symptoms may signal an acute problem such as retinal detachment or stroke rather than the gradual effects of vitamin deficiency.
How should a child with severe FHBL1 be monitored?
A child should have regular monitoring of growth, development, and fat-soluble vitamin levels with a pediatric gastrointestinal or metabolic specialist. Failure to gain weight or unexpected weight loss should be assessed promptly.
What is acanthocytosis, and does every person with FHBL1 need a blood smear?
Acanthocytosis means that some red blood cells look spiny or misshapen under a microscope. It can occur in severe disease or in look-alike conditions, but it is not a routine screening finding in typical people with one altered FHBL1 gene, so a blood smear should be discussed with the treating specialist.
Does a low vitamin K1 level prove that I have a bleeding risk?
No. A low blood vitamin K1 result alone does not establish a bleeding risk; a clinician may also evaluate blood clotting with tests such as PT/INR when appropriate.

Get notified when new evidence is published on Familial hypobetalipoproteinemia 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.

    Wakabayashi T, Takahashi M, Okazaki H, et al.

    Journal of atherosclerosis and thrombosis 2024; (31(7)):1005-1023 doi:10.5551/jat.RV22018.

    PMID: 38710625
  2. 2

    Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia.

    Burnett JR, Hooper AJ

    Free radical biology & medicine 2015; (88(Pt A)):59-62.

    PMID: 26086616
  3. 3

    The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.

    Di Leo E, Eminoglu T, Magnolo L, et al.

    Journal of clinical lipidology 2015; (9(3)):400-5.

    PMID: 26073401
  4. 4

    Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.

    Cefalù AB, Norata GD, Ghiglioni DG, et al.

    Atherosclerosis 2015; (239(1)):209-17.

    PMID: 25618028
  5. 5

    Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study.

    Sürücü Kara İ, Köse E, Mutlu H, et al.

    Journal of clinical lipidology 2025; (19(3)):605-616 doi:10.1016/j.jacl.2025.02.003.

    PMID: 40155282
  6. 6

    A Rare Mutation in The APOB Gene Associated with Neurological Manifestations in Familial Hypobetalipoproteinemia.

    Musialik J, Boguszewska-Chachulska A, Pojda-Wilczek D, et al.

    International journal of molecular sciences 2020; (21(4)) doi:10.3390/ijms21041439.

    PMID: 32093271
  7. 7

    Vitamin K1 as a screening marker to facilitate the genetic diagnosis of class I familial hypobetalipoproteinemia: A prospective cohort study with a systematic review analysis.

    Tanaka M, Okazaki S, Takahashi M, et al.

    Journal of clinical lipidology 2026; (20(8)):1656-1666 doi:10.1016/j.jacl.2026.06.013.

    PMID: 42399142
  8. 8

    Impaired Cytoskeletal and Membrane Biophysical Properties of Acanthocytes in Hypobetalipoproteinemia - A Case Study.

    Cloos AS, Daenen LGM, Maja M, et al.

    Frontiers in physiology 2021; (12()):638027 doi:10.3389/fphys.2021.638027.

    PMID: 33708142
  9. 9

    Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.

    Yilmaz BS, Mungan NO, Di Leo E, et al.

    Clinica chimica acta; international journal of clinical chemistry 2016; (452()):185-90.

    PMID: 26612772

This page explains FHBL1 symptoms and vitamin deficiencies for informational purposes only and does not constitute medical advice. Discuss testing, treatment, and urgent symptoms with your clinician or your child's metabolic or gastrointestinal specialist.